Desal seems a very competitive space. Does Nirobox have serious competitive advantages over the competition? I am just wondering if we can expect growth in that segment going forward or should we be banking on Aspiral and SUBRE to carry the company forward?
Fluence Signs First Commercial SUBRE Order in China, page-27
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add FLC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $108.0M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 10.0¢ | $1.378K | 13.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 54138 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 43216 | 1 |
View Market Depth
| Last trade - 15.42pm 09/08/2024 (20 minute delay) ? |
| FLC (ASX) Chart |